Thoracoscopic Bullectomy Versus Thoracoscopic Bullectomy With Pleurodesis in Primary Spontaneous Pneumothorax

NCT ID: NCT03943069

Last Updated: 2020-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

232 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-01

Study Completion Date

2023-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The exact pathogenesis of PSP is controversial. A few theories has been proposed contributing to the pathogenesity of the PSP as emphysematous like changes (ELCs) which lead to the formation and rupture of the lung bullae or blebs; and increased pleural porosity which is an abnormality of the visceral pleura. The Video-Assisted Thoracoscopic Surgery with bullectomy only is an effective preventive method of PSP recurrence. Adding mechanical pleurodesis to bullectomy is still questionable in the literature. This prospective multicenter study will identify the rate of PSP recurrence after thoracoscopic bullectomy only versus thoracoscopic bullectomy with mechanical pleurodesis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background The pneumothorax may be defined as presence of air in the pleural cavity which then leads to a decrease in lung expansion, and consequently lung collapse. The pneumothorax occurs due to air lodged at the pleural space either between the pleural cavity and the alveolar between the pleural cavity and the atmosphere; or the presence of organisms that produce gases (1).

The pneumothorax can be classified into spontaneous or traumatic. The spontaneous pneumothorax (SP) is either classified into primary SP that has no underlying lung disease; or secondary SP that occurs in underlying lung disease as Chronic Obstructive Pulmonary Diseases (COPDs), or in conjugation with menstrual period causing catamenial pneumothorax (1).

The exact pathogenesis of primary spontaneous pneumothorax (PSP) is controversial. The theories beyond the pathology of PSP has includes: emphysematous like changes (ELCs) which cause formation and rupture of the blebs or bullae; increased pleural porosity which is an abnormality of the visceral pleura seen under fluorescein lighting; and inflammation of the distal airways which lead to fibrotic change and compensatory emphysematous bulla (2). The development of the previous etiologies are linked to genetic predisposition, anatomical abnormalities, connective tissues abnormalities, body mass index under 18.5 kg/m2, decrease caloric intake, and apical ischemia(3).

In the literature there was a superiority in treatment of PSP with the Video-assisted thoracoscopic surgery (VATS) is in compare to thoracotomy, as it has less tissue damage, less postoperative pain, less hospitalization stay, better cosmetic outcome, and earlier return to normal daily life activities (4). The debate on the ideal preventive method of PSP recurrence using VATS spotlights on the main etiologies of the treatment of bleb and bullae by the bullectomy and the pleural abnormalities by pleurodesis(5).

VATS with bullectomy alone is an effective method of decreasing the chance of PSP recurrence, while additive of mechanical pleurodesis is questionable as different studies showed variable results(6-8). This multicenter randomized control trial study will compare the recurrence rate of PSP post thoracoscopic bullectomy alone in compare with thoracoscopic bullectomy in addition to mechanical pleurodesis.

Methodology Study setting This is a randomized control trial study which will be held at the following hospitals: King Fahad Hospital of University (KFHU), Qatif Central Hospital (QCH), King Fahad Specialist Hospital Dammam (KFSH), and John Hopkins Aramco Healthcare.

The Study will include all Saudi and non-Saudi patients, male or female, age between 16-45-year-old, diagnosed with PSP. The exclusion criteria: any patient with previous thorax surgery history, patient undergoing thoracotomy and patient with hemothorax.

Sample Size In order to calculate the sample size, the recurrence rate of the Thoracoscopic Bullectomy and Mechanical Pleurodesis (TB+MP) was conservatively estimated to be lower than 2%, whilst the recurrence rate of the Thoracoscopic Bullectomy (TB) group was estimated to be 12%. To attain a study power of 80% with an alpha error of 0.05 the sample size was estimated to be 202. Assuming a 15% loss to follow-up rate, at least 232 subjects between groups will be selected.

Randomization and Masking Computer generated randomization will be used, and to ensure random allocation and concealment, surgeons from the multiple centers that have been included will contact a central randomization service provided by a distant and blinded research fellow not involved in treatments upon arrival of patients who fulfill the inclusion criteria that have been set a priori to either the TB group or the Thoracoscopic TB+MP group.

Surgical technique The patients will be operated under general anesthesia with ventilation of one lung using double-lumen endotracheal tube.

Two or three ports thoracoscopic technique will be used to open and visualize the thoracic cavity. The procedure whether bullectomy alone or bullectomy with pleurodesis will be selected randomly preoperatively after informed consent. Wedge resection using an endoscopic stapler will target the bullae. In addition to the bullectomy the investigators will do mechanical pleurodesis according to the randomization by pleural abrasion, and consistent techniques for pleural abrasion the investigators will maintain with regard to the extent and aggressiveness of abrasion. In the mechanical pleurodesis, the mesothelial layer of the parietal pleura will be abraded from the cupola of the thoracic cavity apex to the 5th intercostal space.

Post-operatively a traditional chest drainage system will be connected to the patient's chest for monitoring the air-leak and fluid drainage. The traditional chest drainage consists of drainage chamber, water-seal chamber, and suction control.

Data Collection Medical records; chest x-ray or Computed Tomographic Scan (CT-scan) result; presenting symptoms; operative time; intraoperative blood loss; postoperative thoracic drainage amount, air-leakage duration, chest tube duration and pain scale score; length of hospital stay; and details of follow-up will be assessed by the same treating inverstigator.

All patients will be followed-up in one week, one months, three months and six months looking for pneumothorax recurrence. Nevertheless, patients will be instructed to return to the emergency department if they develop chest pain, shortness of breath, or if symptoms are suggestive of pneumothorax recurrence. All recurrence cases will be confirmed by chest X-ray or CT-scan.

Statistical analysis STATA Statistical Software version 15 will be used for data analysis. Analyses will commence with a description of the population where percentages and means along with their respective standard deviations will be reported. Multi-variate analyses will be based on the intention-to-treat principle. All tests of significance will be 2-sided. A comparison will be made between the two treatment groups based on the amount of drainage in (ml) using the hazard ratio and its respective confidence interval which will be calculated from a Cox proportional hazards model. All outcome measures will be adjusted for age, sex, smoking index, BMI, and physical activity. A p-value of less than 0.05 will be considered as statistically significant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thoracic Surgical Procedures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with PSP

Patient who will be admitted with primary spontaneous pneumothorax.

Group Type EXPERIMENTAL

Thoracoscopic bullectomy alone

Intervention Type PROCEDURE

Thoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae.

Thoracoscopic bullectomy with pleurodesis

Intervention Type PROCEDURE

Thoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae.in addition to mechanical pleurodesis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thoracoscopic bullectomy alone

Thoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae.

Intervention Type PROCEDURE

Thoracoscopic bullectomy with pleurodesis

Thoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae.in addition to mechanical pleurodesis.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VATS Bullectomy VATS Bullectomy with pleurodesis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary spontaneous pneumothorax
* Male or female
* Age 16-45

Exclusion Criteria

* Hemopneumothorax
* Previous thoracic surgical intervention
* Patient undergoing thoracotomy
Minimum Eligible Age

16 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Fahad Specialist Hospital Dammam

OTHER

Sponsor Role collaborator

Qatif Central Hospital

OTHER

Sponsor Role collaborator

Johns Hopkins Aramco Healthcare

OTHER

Sponsor Role collaborator

Imam Abdulrahman Bin Faisal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hatem Elbawab

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Imam Abdulrahman bin Faisal University

Dammam, Eastern Province, Saudi Arabia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hatem Y El-Bawab, Doctorate

Role: CONTACT

Phone: +966537395536

Email: [email protected]

Yasser M Aljehani

Role: CONTACT

Phone: +966542253333

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Noppen M, De Keukeleire T. Pneumothorax. Respiration. 2008;76(2):121-7. doi: 10.1159/000135932. Epub 2008 Jun 26.

Reference Type BACKGROUND
PMID: 18708734 (View on PubMed)

Grundy S, Bentley A, Tschopp JM. Primary spontaneous pneumothorax: a diffuse disease of the pleura. Respiration. 2012;83(3):185-9. doi: 10.1159/000335993. Epub 2012 Feb 15.

Reference Type BACKGROUND
PMID: 22343477 (View on PubMed)

Noppen M. Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev. 2010 Sep;19(117):217-9. doi: 10.1183/09059180.00005310.

Reference Type BACKGROUND
PMID: 20956196 (View on PubMed)

Huh U, Kim YD, Cho JS, I H, Lee JG, Lee JH. The Effect of Thoracoscopic Pleurodesis in Primary Spontaneous Pneumothorax: Apical Parietal Pleurectomy versus Pleural Abrasion. Korean J Thorac Cardiovasc Surg. 2012 Oct;45(5):316-9. doi: 10.5090/kjtcs.2012.45.5.316. Epub 2012 Oct 9.

Reference Type BACKGROUND
PMID: 23130305 (View on PubMed)

Noppen M, Baumann MH. Pathogenesis and treatment of primary spontaneous pneumothorax: an overview. Respiration. 2003 Jul-Aug;70(4):431-8. doi: 10.1159/000072911.

Reference Type BACKGROUND
PMID: 14512683 (View on PubMed)

Alayouty HD, Hasan TM, Alhadad ZA, Omar Barabba R. Mechanical versus chemical pleurodesis for management of primary spontaneous pneumothorax evaluated with thoracic echography. Interact Cardiovasc Thorac Surg. 2011 Nov;13(5):475-9. doi: 10.1510/icvts.2011.270280. Epub 2011 Aug 9.

Reference Type BACKGROUND
PMID: 21828109 (View on PubMed)

Zhang Z, Du L, Feng H, Liang C, Liu D. Pleural abrasion should not routinely preferred in treatment of primary spontaneous pneumothorax. J Thorac Dis. 2017 Apr;9(4):1119-1125. doi: 10.21037/jtd.2017.03.124.

Reference Type RESULT
PMID: 28523168 (View on PubMed)

Horio H, Nomori H, Kobayashi R, Naruke T, Suemasu K. Impact of additional pleurodesis in video-assisted thoracoscopic bullectomy for primary spontaneous pneumothorax. Surg Endosc. 2002 Apr;16(4):630-4. doi: 10.1007/s00464-001-8232-5. Epub 2002 Jan 9.

Reference Type RESULT
PMID: 11972203 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ThorSurg_2014-04

Identifier Type: -

Identifier Source: org_study_id